1. Home
  2. NNBR vs MDAI Comparison

NNBR vs MDAI Comparison

Compare NNBR & MDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NN Inc.

NNBR

NN Inc.

HOLD

Current Price

$1.18

Market Cap

63.7M

Sector

Industrials

ML Signal

HOLD

MDAI

Spectral AI Inc.

HOLD

Current Price

$1.55

Market Cap

55.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NNBR
MDAI
Founded
1980
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
63.7M
55.9M
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
NNBR
MDAI
Price
$1.18
$1.55
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$3.25
AVG Volume (30 Days)
541.4K
279.0K
Earning Date
10-29-2025
11-11-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$424,005,000.00
$23,168,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$5.31
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.10
$1.04
52 Week High
$4.67
$3.25

Technical Indicators

Market Signals
Indicator
NNBR
MDAI
Relative Strength Index (RSI) 35.66 44.86
Support Level $1.17 $1.42
Resistance Level $1.24 $1.57
Average True Range (ATR) 0.10 0.10
MACD 0.02 0.00
Stochastic Oscillator 20.03 38.78

Price Performance

Historical Comparison
NNBR
MDAI

About NNBR NN Inc.

NN Inc is a diversified industrial company that combines engineering and production capabilities with in-depth materials science expertise to design and manufacture high-precision solutions and components. It operates in two business segments: mobile solutions and power solutions. The mobile solutions segment involves growth in the general industrial and automotive end markets. Its power solutions segment involves growth in the electrical and aerospace and defense end markets.

About MDAI Spectral AI Inc.

Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.

Share on Social Networks: